Dödligt virus från Kina orsakar panik (SARS-CoV-2, COVID-19)

A paper published on Zenodo (DOI 10.5281/zenodo.4119263) by Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS), illuminates new scientific observations and conclusions documenting that the SARS-CoV-2 pandemic began at the General Hospital of Central Theater Command of People's Liberation Army (PLA Hospital) in Wuhan, China, located at 627 Wulon Road, Wuchang District, Wuhan. International biospecimen data repositories indicate as early as December 10, 2019 COVID patient records were being created by PLA personnel, weeks before the Chinese government informed the WHO of the pandemic.

The PLA Hospital is about one mile from the Wuhan Institute of Virology (WIV) and the closest hospital to WIV. Both the PLA Hospital and WIV are serviced by Line 2 of the Wuhan Metro System. The Hunan Seafood Market is also located adjacent to Line 2. All patients between December 1st, 2019 and early January 2020 were first seen at hospitals that also are serviced by Line 2 of the Metro system.
With 40 hospitals located near seven of the nine Metro Lines, the likelihood that all early patients were seen at hospitals only near Line 2 by chance is about 1 in 68,500 (p-value = 0.0000146). The inference then would be that the early spread of SARS-CoV-2 was through human-to human transmission on Line 2.